HomeAnalytical R&D JobsSMS Pharmaceuticals walk-in interview for Freshers & Experience on 14th Nov 2026

SMS Pharmaceuticals walk-in interview for Freshers & Experience on 14th Nov 2026

Verified Walk-In Interview
Hyderabad / Bangalore / India

Company: SMS Pharmaceuticals
Department(s): Process R&D (PR&D)
Qualification: B.Pharm / M.Pharm / M.Sc / B.Sc / Diploma / Engineering
Experience: 0–5 Years
Interview Date: 14th Nov 2026 (9:00 AM to 4:00 PM)
Job Location: Hyderabad / Bangalore / India

1. Editorial Overview: SMS Pharmaceuticals Walk-In Drive & Career Opportunity

SMS Pharmaceuticals has announced an in-person walk-in interview drive welcoming talented life sciences and pharmaceutical professionals for roles across Process R&D (PR&D). This recruitment initiative offers candidates an exceptional opportunity to join a compliance-driven pharmaceutical environment that emphasizes scientific rigor, cGMP standards, and continuous technical growth.

Professionals selected during this drive will work in cutting-edge laboratory and manufacturing facilities, collaborating with senior industry mentors on commercial scale-up, regulatory compliance, and technology transfer. The organization provides structured induction, regular technical training on international regulatory expectations (USFDA, EMA, WHO, CDSCO), and rewarding career advancement pathways.

2. Department-Wise Scope & Daily Technical Responsibilities

Candidates appearing for this recruitment drive will be assessed on their practical domain expertise, equipment familiarity, and regulatory compliance discipline within Process Research & Development (Process R&D / Synthesis):

A. Synthetic Route Scouting & Process Optimization

Designing scalable, safe, cost-effective, and non-infringing synthetic pathways for complex active pharmaceutical ingredients (APIs), advanced intermediates, and peptide molecules. Identifying raw material critical quality attributes (CQAs) and optimizing reaction parameters (temperature, solvent choice, stoichiometric ratios, catalyst loading) to maximize yield and atom economy.

B. Critical Process Parameters (CPPs) & Impurity Profiling

Systematically establishing process design spaces under ICH Q8 (Quality by Design) guidelines. Identifying and tracking reaction impurities, degradation products, and potential genotoxic/mutagenic impurities according to ICH M7 thresholds. Developing robust purging strategies during downstream crystallization and isolation stages.

C. Reaction Safety Calorimetry & Plant Scale-Up

Evaluating thermochemical hazards using reaction calorimetry (RC1, DSC, ARC) to determine reaction enthalpy (ΔH) and adiabatic temperature rise (ΔTad). Partnering with pilot plant and tech transfer teams to manage mass and heat transfer limitations during scale-up to commercial reactors.

3. Top 5 Technical Interview Questions & Answers for SMS Pharmaceuticals

Our editorial team reviewed standard interview benchmarks to compile the top technical questions frequently asked during technical rounds for these roles:

Q1: What are the primary objectives of Route Scouting in Process Chemistry?

Answer: Route Scouting aims to identify the most commercially viable, safe, scalable, and atom-economical synthetic pathway for an API. It prioritizes minimizing hazardous reagents, reducing overall step count, avoiding genotoxic intermediates, achieving high enantiomeric/chemical purity, and utilizing non-infringing intellectual property routes.

Q2: How are Genotoxic and Mutagenic Impurities assessed according to ICH M7 guidelines?

Answer: ICH M7 provides a practical framework for identifying, categorizing, and controlling mutagenic impurities in pharmaceuticals. Impurities are assigned to Classes 1 through 5 based on structural alerts and Ames bacterial mutagenicity assays. For Class 2 and 3 mutagens, acceptable intake is derived from the Threshold of Toxicological Concern (TTC) of 1.5 µg/day for lifetime exposure.

Q3: What is Reaction Calorimetry and why is it essential before plant scale-up?

Answer: Reaction Calorimetry measures the heat generated (enthalpy of reaction, ΔH) and the heat flow rate during chemical reactions. It determines adiabatic temperature rise (ΔTad), identifies runaway potential, and establishes thermal stability parameters to design adequate plant cooling systems and safe dosing rates.

Q4: What is Polymorph Screening and why is it critical in API crystallization?

Answer: Polymorphism is the ability of a solid API to exist in multiple crystalline forms. Different polymorphs possess varying solubilities, dissolution rates, bioavailability, and mechanical flow properties. Process R&D optimizes solvent selection, cooling profiles, and seed addition to reliably deliver the thermodynamically stable crystalline polymorph.

Q5: Explain the importance of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs).

Answer: Under ICH Q8 (Quality by Design), CQAs are physical, chemical, or microbiological properties of an intermediate or API that must be within an appropriate limit to ensure desired product quality. CPPs are process parameters (e.g., temperature, pH, agitation speed, feed rate) whose variability impacts a CQA and must therefore be controlled within proven acceptable ranges.

4. Walk-In Event Schedule & Venue Information

ParameterDetails
Interview Date14th Nov 2026
Registration Timing9:00 AM to 4:00 PM
Venue AddressSMS R&D Centre, Sy. No. 186, 189 & 190, Gagillapur (V), Dundigal, Gandimaisamma (M), Medchal-Malkajgiri District, Hyderabad, Telangana.
Required Experience0–5 Years
Educational EligibilityB.Pharm / M.Pharm / M.Sc / B.Sc / Diploma / Engineering

5. Walk-In Interview Day Checklist & Dossier Strategy

To ensure a smooth registration and verification process on the day of the drive, candidates should prepare the following physical documentation dossier:

  • Curriculum Vitae: 3 printed copies of an updated resume detailing specific instrumental proficiencies, scale of operations, and major academic/industrial projects.
  • Educational Records: Original certificates and two self-attested photocopies of all mark sheets (10th, 12th, Graduation, and Post-Graduation) along with provisional degree certificates.
  • Employment Credentials (Experienced Candidates): Current employer appointment letter, latest compensation revision letter (CTC annexure), last 3 months pay slips, and official relieving letters from prior organizations.
  • Government Identification: Original and photocopies of a valid photo ID (Aadhaar Card, PAN Card, or Passport).
  • Photographs: 3 recent passport-sized color photographs.
  • Reporting Etiquette: Candidates should plan to arrive 30–45 minutes prior to the registration window to complete attendance formalities before tokens close.

6. Official Verification Sources & Remote Application Route

Verification Source: This recruitment drive is organized by the Talent Acquisition team of SMS Pharmaceuticals. Candidates are strongly encouraged to verify ongoing job updates and corporate news through official corporate channels.

If you are unable to attend the walk-in drive in person, you may submit your updated resume directly through SMS Pharmaceuticals’s official careers portal or corporate talent acquisition contact.

Anti-Fraud Advisory: SMS Pharmaceuticals and PharmaWalks maintain a zero-fee recruitment policy. Neither organization charges processing fees, security deposits, or interview registration payments at any stage. All genuine recruitment communication originates exclusively from authorized corporate email domains.

About SMS Pharmaceuticals

SMS Pharmaceuticals Ltd., established in 1990 and headquartered in Hyderabad, India, is a leading global player in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and complex intermediates across therapeutic segments such as anti-ulcer, anti-diabetic, anti-inflammatory, anti-retroviral, and others. What began as a single-facility, single-product company has grown into a listed, multi-location integrated pharmaceutical group with four multi-product manufacturing facilities, two dedicated research centers, and over 1,000 employees, supported by state-of-the-art R&D and manufacturing capabilities (smspharma.com / who-we-are). Recognized with export house status in 1997-98, the company today serves a growing domestic and international customer base.

RELATED JOBS

Follow Us

2,000FansLike
5,468FollowersFollow
2,458FollowersFollow
1,379SubscribersSubscribe

LEAVE A REPLY

Most Popular